Cite
HARVARD Citation
Temraz, S. et al. (2016). Dual targeting of HER3 and EGFR in colorectal tumors might overcome anti-EGFR resistance. Critical reviews in oncology/hematology. pp. 151-157. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Temraz, S. et al. (2016). Dual targeting of HER3 and EGFR in colorectal tumors might overcome anti-EGFR resistance. Critical reviews in oncology/hematology. pp. 151-157. [Online].